Abstract
We describe two half-siblings with monocarboxylate transporter 1 (MCT1, SLC16A1) deficiency, a defect on ketone body utilization, that has only recently been identified (van Hasselt et al., N Engl J Med, 371:1900–1907, 2014) as a cause for recurrent ketoacidoses. Our index patient is a boy with non-consanguineous parents who had presented acutely with impaired consciousness and severe metabolic ketoacidosis following a 3-day history of gastroenteritis at age 5 years. A 12.5-year-old half-brother who shared the proband’s mother also had a previous history of recurrent ketoacidoses. Results of mutation and enzyme activity analyses in proband samples advocated against methylacetoacetyl-coenzyme A thiolase (“beta-ketothiolase”) and succinyl-coenzyme A: 3-oxoacyl coenzyme A transferase (SCOT) deficiencies. A single heterozygous c.982C>T transition in the SLC16A1 gene resulting in a stop mutation (p.Arg328Ter) was detected in both boys. It was shared by their healthy mother and by the proband’s half-sister, but was absent in the proband’s father. MCT1 deficiency may be more prevalent than is apparent, as clinical manifestations can occur both in individuals with bi- and monoallelic mutations. It may be an important differential diagnosis in recurrent ketoacidosis with or without hypoglycemia, particularly in the absence of any specific metabolic profiles in blood and urine. Early diagnosis may enable improved disease management. Careful identification of potential triggers of metabolic decompensations in individuals even with single heterozygous mutations in the SLC16A1 gene is indicated.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Fei F, Guo X, Chen Y, Liu X, Tu J, Xing J, Chen Z, Ji J, He X (2015) Polymorphisms of monocarboxylate transporter genes are associated with clinical outcomes in patients with colorectal cancer. J Cancer Res Clin Oncol 141:1095–1102
Fukao T, Song XQ, Yamaguchi S, Hashimoto T, Orii T, Kondo N (1996) Immunotitration analysis of cytosolic acetoacetyl-coenzyme A thiolase activity in human fibroblasts. Pediatr Res 39:1055–1058
Fukao T, Shintaku H, Kusubae R, Zhang X-Q, Nakamura K, Kondo M, Kondo N (2004) Patients homozygous for the T435N mutation of succinyl-CoA:3-ketoacid CoA transferase (SCOT) do not show permanent ketosis. Pediatr Res 56:858–863
Fukao T, Maruyama S, Ohura T, Hasegawa Y, Toyoshima M, Haapalainen AM, Kuwada N, Imamuram I, Yuasa I, Wierenga RK, Yamaguchi S, Kondo N (2011) Three Japanese patients with beta-ketothiolase deficiency who share a mutation, c.431A>C (H144P) in ACAT1. Subtle abnormality in urinary organic acid analysis and blood acylcarnitine analysis using tandem mass spectrometry. JIMD Rep 3:107–115
Fukao T, Mitchell G, Sass JO, Hori T, Orii K, Aoyama Y (2014) Ketone body metabolism and its defects. J Inherit Metab Dis 37:541–551
Martín-Venegas R, Brufau MT, Mañas-Cano O, Mercier Y, Nonis MK, Ferrer R (2012) Monocarboxylate transporter 1 is up-regulated in Caco-2 cells by the methionine precursor DL-2-hydroxy-(4-methylthio)butanoic acid. Vet J 202:555–560
Mitchell GA, Kassovska-Bratinova S, Boukaftane Y, Robert MF, Wang SP, Ashmarina L, Lambert M, Lapierre P, Potier E (1995) Medical aspects of ketone body metabolism. Clin Invest Med 18:193–216
Sakazaki H, Hirayama K, Murakami S, Yonezawa S, Shintaku H, Sawada Y, Fukao T, Watanabe H, Orii T, Isshiki G (1995) A new Japanese case of succinyl-CoA: 3-ketoacid CoA-transferase deficiency. J Inherit Metab Dis 18:323–325
Sass JO (2012) Inborn errors of ketogenesis and ketone body utilization. J Inherit Metab Dis 35:23–28
van Hasselt PM, Ferdinandusse S, Monroe GR, Ruiter JP, Turkenburg M, Geerlings MJ, Duran K, Harakalova M, van der Zwaag B, Monavari AA, Okur I, Sharrard MJ, Cleary M, O’Connell N, Walker V, Rubio-Gozalbo ME, de Vries MC, Visser G, Houwen RH, van der Smagt JJ, Verhoeven-Duif NM, Wanders RJ, van Haaften G (2014) Monocarboxylate transporter 1 deficiency and ketone utilization. N Engl J Med 371:1900–1907
Acknowledgments
J.O. Sass is grateful for the financial support by the Hans Hermann Voss-Stiftung (Wipperfürth, Germany) and by the Fondation Claude et Giuliana (Vaduz, Liechtenstein) and thanks Ms. Corinne Gemperle-Britschgi and Ms. Lisa Stübbe for the analytical support.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Additional information
Communicated by: Robert Steiner
Appendices
One-Sentence Take-Home Message
MCT1 deficiency is an only recently described cause of recurrent ketoacidosis with clinical manifestation observed both in individuals with bi- or monoallelic mutations.
Compliance with Ethics Guidelines
Conflict of Interest
Shanti Balasubramaniam, Barry Lewis, Lawrence Greed, David Meili, Annegret Flier, Raina Yamamoto, Karmen Bilić, Claudia Till, and Jörn Oliver Sass declare have no conflict of interest.
Informed Consent and Animal Rights
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000.
The investigated family has agreed to the publication and provided informed consent. This article does not contain any studies with animal subjects performed by the any of the authors.
Details of the Contributions of Individual Authors
SB was the physician in charge of the family. BL, LG, DM, AF, RY, KB, CT, and JOS performed/supervised/interpreted laboratory investigations. SB and JOS have drafted the manuscript. All authors have read/critically revised the manuscript.
Rights and permissions
Copyright information
© 2015 SSIEM and Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Balasubramaniam, S. et al. (2015). Heterozygous Monocarboxylate Transporter 1 (MCT1, SLC16A1) Deficiency as a Cause of Recurrent Ketoacidosis. In: Morava, E., Baumgartner, M., Patterson, M., Rahman, S., Zschocke, J., Peters, V. (eds) JIMD Reports, Volume 29. JIMD Reports, vol 29. Springer, Berlin, Heidelberg. https://doi.org/10.1007/8904_2015_519
Download citation
DOI: https://doi.org/10.1007/8904_2015_519
Received:
Revised:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-53277-5
Online ISBN: 978-3-662-53278-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)